DeSci-focused DAO community funds cancer research
VitaDAO community agreed to fund early-stage cancer research through the launch of a biotech company named Matrix Biosciences.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
VitaDAO community agreed to fund early-stage cancer research through the launch of a biotech company named Matrix Biosciences.
Why this matters
This research story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
Funds are buying crypto stocks. Are they exposed to less risk — or more?
Cathie Wood's ARK Invest bought roughly $77 million of crypto stocks in June, adding $44 million of Coinbase (COIN), $25.25 millio...
Distressed-debt funds negotiate with bankers over Strategy’s preferred shares
The negotiations highlight the potential instability of Bitcoin-backed corporate strategies, prompting a reevaluation of similar f...
Banks report highest historical exposure to hedge funds, and crypto is part of the equation
Increased bank exposure to hedge funds amplifies systemic risk, intertwining traditional finance with crypto volatility and potent...
Sovereign wealth funds favor regulated access to Bitcoin and digital assets
Sovereign wealth funds' preference for regulated digital asset investments signals growing institutional acceptance, potentially s...
Step Finance exploiter sells $21M in SOL, buys ETH and launders funds through Tornado Cash
The exploit highlights vulnerabilities in DeFi security, impacting investor trust and emphasizing the need for robust cross-chain...
Samsung and Dunamu Say They Never Agreed to Join Open Standard’s OUSD Stablecoin Consortium
Samsung Electronics, Dunamu, and several other South Korean companies say they were listed as founding partners of the OUSD stable...